The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.00
Ask: 65.00
Change: -0.50 (-0.78%)
Spread: 2.00 (3.175%)
Open: 64.50
High: 64.50
Low: 64.00
Prev. Close: 64.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

Thu, 28th Sep 2023 14:24

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Dar Global PLC - luxury international real estate developer - In the six months that ended June 30, pretax profit multiplies to GBP20.8 million from GBP3.7 million a year earlier. Revenue also multiplies to GBP108.4 million from GBP27.5 million. Chief Executive Officer Ziad El Chaar says: "2023 has been a milestone year for the company with our successful listing on the London Stock Exchange in February representing a significant step forward in supporting our ambitious growth trajectory. The second half has started strongly and we are well positioned to weather some of the challenges facing the sector through the strength of our balance sheet, building partnerships with other global luxury brands and further expanding our pipeline of opportunities."

----------

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - In the six months that ended June 30, pretax loss widens to GBP4.3 million from GBP1.1 million. Posts no revenue, unchanged, while administrative expenses widen to GBP3.9 million from GBP1.1 million. Chief Executive Officer Vladislav Sandler says: "While the placing of Hemo-Car-T on clinical hold was a setback, we are clear on the particular area in which additional information is required, and we are encouraged by the [US Food & Drug Administration]'s response to our plans to resolve the issues. We remain confident and committed to progressing Hemo-Car-T to clinical trials as the company's next step. We have put measures in place to allow us to achieve this milestone, including the new agreement with Prevail InfoWorks and the investment by Prevail Partners, which gives a clear signal of the project's value even at this pre-clinical phase. Meanwhile, the prospects for our other cutting-edge assets continue to be positive, and CBR in particular is beginning to attract real attention."

----------

Lansdowne Oil & Gas PLC - North Celtic Sea-focused oil and gas company - In the six months that ended June 30, pretax loss widens to GBP16.1 million from GBP158,000 a year earlier. This is due to a one-off impairment of intangible assets of GBP15.9 million. Says it remains confident of amicable resolution with Ireland over Barryroe oil field, after receiving a letter in May from the Irish Department of the Environment, Climate & Communications, advising that the minister would not grant the lease undertaking, as sought, on grounds of financial capability. Says: "We continue to maintain that the failure to allow the Barryroe oil and gas field to progress to development is against the best interests of Ireland."

----------

Metals One PLC - London-based mining company, which is focused on battery metals projects in Finland and Norway - In the six months that ended June 30, pretax loss narrows to GBP118,893 from GBP154,371 a year earlier, as administrative expenses narrow to GBP118,893 from GBP184,017. Chair Alastair Clayton says: "The six-month period...was incredibly busy for the company as it worked towards completion of its [initial public offering] and concurrent acquisitions of European brownfield battery metals projects which occurred after the reporting period. With European brownfield projects, experienced partners, and funded work programmes in place, our projects are well positioned for rapid advancement as we seek to establish ethically mined sources of critical minerals, including nickel, in Europe, close to future customers. Exploration in Norway is well underway with Kingsrose, whilst in Finland we are finalising plans to commence phase one drilling in the near future. We look forward to updating shareholders on further news as we continue our work programmes."

----------

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - In the six months that ended June 30, pretax loss narrows to GBP1.6 million from GBP1.7 million a year earlier. Total income during the period was up to GBP1.2 million from GBP656,000 a year earlier, with revenue up to GBP770,000 from GBP391,000. Chief Executive Officer Ilian Iliev says: "During the first half of 2023 we have made significant progress and achieved important milestones as we continue to successfully execute on our 'evergreen' strategy, covering core operating costs through a combination of corporate finance fees and value creation services fees via our wholly owned subsidiary, EMV Capital. We have also demonstrated our ability to generate profitable partial exits from our portfolio, even in the absence of a strong [mergers & acquisitions] or [initial public offering] market. This essential funding for our portfolio companies has helped to facilitate the execution of their growth strategies and preparations for forthcoming scale-up investment rounds as well as supporting the appreciating fair value of NetScientific's direct holdings. In such a challenging venture capital landscape, characterised by macroeconomic volatility and industry fluctuations, our in-house fundraising capacity distinguishes us from many of our peers."

----------

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
14 Mar 2019 10:35

NetScientific Not Aware Of Reason Behind Recent Share Rise

LONDON (Alliance News) - NetScientific PLC on Thursday said it is not aware of any reason behind a significant rise in its share price.NetScientific shares were trading up 13% at 14.08 each

Read more
1 Mar 2019 13:15

NetScientific Cancels Meeting Amid Shareholder Opposition To Delisting

LONDON (Alliance News) - NetScientific PLC on Friday said it believes that the resolution for the cancellation of its shares from AIM market, to be proposed at a general meeting of the firm, will

Read more
25 Feb 2019 16:42

Invesco Divests Entire NetScientific Holding From 19% (ALLISS)

LONDON (Alliance News) - NetScientific PLC said Monday that Invesco Ltd divested its entire stake in the company.In a deal concluded on Friday, Invesco sold its 19.74% interest in the down

Read more
21 Feb 2019 18:08

NetScientific Shareholder Increases Interest To 30% After Transaction (ALLISS)

LONDON (Alliance News) - NetScientific PLC said on Thursday that shareholder M A Lawson has increased the holding in the company to 30% from 9.7%.Shares in the healthcare technology company

Read more
18 Feb 2019 17:46

JO Hambro Capital Management Sells Entire Holding In NetScientific (ALLISS)

LONDON (Alliance News) - NetScientific PLC on Monday said JO Hambro Capital Management Ltd no longer has a stake in the medical technology manufacturer after a transaction on Friday last to that,

Read more
15 Feb 2019 12:36

NetScientific Plans To Leave AIM Market After Failing To Agree Sales (ALLISS)

LONDON (Alliance News) - Shares in NetScientific PLC on Friday said it will be leaving the London Stock Exchange following a failure to find a buyer.The stock was down 59% on Friday at 3.30

Read more
15 Jan 2019 11:56

NetScientific Shares Plunge On Lack Of Takeover Approaches

LONDON (Alliance News) - Shares in NetScientific PLC slumped on Tuesday as it terminated its formal sales process, with no approaches made for its acquisition.Shares in NetScientific fell a

Read more
20 Dec 2018 15:02

No suitors for NetScientific as it suggests delisting

(Sharecast News) - Healthcare intellectual property commercialisation group NetScientific updated the market on its strategic review on Thursday, which it announced in late November.

Read more
26 Nov 2018 16:54

Netscientific Investee Mergers With Nasdaq-Listed Edge Therapeutics

LONDON (Alliance News) - Netscientific PLC said Monday investee PDS Biotechnology Corp has agreed to a merger with Nasdaq-listed Edge Therapeutics Inc, as the company also conducts a strategic the

Read more
1 Nov 2018 13:41

NetScientific Portfolio Firm Vortex Inks Manufacturing Agreement

LONDON (Alliance News) - NetScientific PLC said Thursday that its 66%-owned US-based portfolio company, Vortex BioSciences, has entered into a global manufacturing agreement with Stratec GmbH to a

Read more
28 Sep 2018 15:41

NetScientific Interim Revenue Down But Loss Narrows On Lower Expenses

LONDON (Alliance News) - NetScientific PLC on Friday said its loss narrowed in the first half of 2018 following a decline in operating costs.The healthcare investment company said its loss

Read more
20 Sep 2018 13:47

Netscientific Portfolio Firm ProAxsis Selected For Respiratory Study

LONDON (Alliance News) - Netscientific PLC said Thursday said ProAxsis Ltd, a company in its portfolio, had two products selected for inclusion in an upcoming medical trial funded by the European

Read more
15 Aug 2018 14:43

NetScientific's Wanda launches 'CareLink' digital health product

(Sharecast News) - Transatlantic healthcare IP commercialisation group NetScientific announced on Wednesday that portfolio company Wanda, which it said uses machine learning to help healthcare providers better manage the risk and care of patients, has launched its new digital health application 'Wanda CareLink'.

Read more
15 Aug 2018 11:10

NetScientific Investee Launches Wanda CareLink Mobile Application

LONDON (Alliance News) - NetScientific PLC on Wednesday said its portfolio company Wanda launched its new digital health application Wanda CareLink.The investment company said Wanda uses to

Read more
2 Aug 2018 13:23

NetScientific Portfolio Firm ProAxsis Gains CE Mark For Immunoassay

LONDON (Alliance News) - NetScientific PLC said Thursday its portfolio company ProAxsis Ltd has successfully registered a CE Mark for its third respiratory immunoassay.The CE Mark has been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.